Biotech Values

[DewDiligence]

…if mnta states very specifically they have [M118] partner(s) in waiting pending a successful 2b in a specific trial setting. the most bullish scenario would be to go straight to a registrational trial with a partner, and needing the cash up front to secure their share of trial cost (i may be in fantasy land here)

I’d like to be able to agree with you, but I don’t think your scenario has any chance whatsoever of happening. Rick Shea’s not mentioning M118 by name in the passage I quoted from BioWorld Today is like the dog that didn’t bark in the whodunit.

The M118 program is now officially on life support. If no new trial is started in the next six months, I will update the status to dead.